• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简化儿童复杂性阑尾炎的一线抗菌治疗方案与更好地遵循指南和减少抗生素使用有关。

Simplification of first-line antibacterial regimen for complicated appendicitis in children is associated with better adherence to guidelines and reduced use of antibiotics.

机构信息

Department of Anesthesiology, Rennes University Hospital, Rennes, France.

Department of Pediatric Surgery, Rennes University Hospital, Rennes, France.

出版信息

Int J Antimicrob Agents. 2018 Aug;52(2):293-296. doi: 10.1016/j.ijantimicag.2018.04.010. Epub 2018 Apr 18.

DOI:10.1016/j.ijantimicag.2018.04.010
PMID:29678565
Abstract

Acute appendicitis in children requires early surgery and short-course antibiotics active against Enterobacteriaceae and anaerobes. Although an aminoglycoside-containing three-drug regimen has been used successfully for decades, simpler regimens with similar efficacy are increasingly used. This study evaluated the impact of a switch from the combination of cefotaxime, metronidazole and gentamicin (regimen 1) to piperacillin/tazobactam (regimen 2) as first-line regimen for complicated acute appendicitis in children. In total, 171 children were enrolled [median (IQR) age, 10 (6-13) years], treated with regimen 1 (n = 80) or regimen 2 (n = 91) following surgery for complicated acute appendicitis. The two groups were comparable except for surgical approach (through laparoscopy in 46% vs. 88% for regimens 1 and 2, respectively; P < 0.001). Post-operative complications and duration of hospital stay were similar. Deviations from antibacterial treatment protocol decreased from 36% (29/80) to 14% (13/91) (P < 0.001), with a dramatic reduction in antibacterial treatment duration from median (IQR) of 15 (12-16) days to 5 (5-8) days (P < 0.001). Post-operative intra-abdominal abscess developed in 32 children (18.7%). Female sex (OR = 2.76, 95% CI 1.18-6.48; P = 0.02) and sepsis/septic shock on admission (OR = 4.72, 95% CI 1.12-19.97; P = 0.035) were independently associated with post-operative intra-abdominal abscess, but not antibacterial regimen. This study shows that simplification of first-line antibacterial regimen for complicated appendicitis in children was associated with reduced protocol deviation, reduced duration of antibiotics, and similar outcomes (post-operative complications and duration of hospital stay).

摘要

儿童急性阑尾炎需要早期手术和针对肠杆菌科和厌氧菌的短疗程抗生素治疗。虽然含有氨基糖苷类药物的三联疗法已成功应用数十年,但越来越多的简单方案具有相似的疗效。本研究评估了将头孢噻肟、甲硝唑和庆大霉素(方案 1)三联疗法转换为哌拉西林/他唑巴坦(方案 2)作为儿童复杂性急性阑尾炎一线治疗方案的影响。共有 171 名儿童入组[中位数(IQR)年龄,10(6-13)岁],接受了手术治疗复杂性急性阑尾炎后,分别接受了方案 1(n=80)或方案 2(n=91)治疗。两组除手术途径(方案 1为腹腔镜手术占 46%,方案 2为 88%;P<0.001)外,其他方面无差异。术后并发症和住院时间相似。抗菌治疗方案的偏差从 36%(29/80)减少到 14%(13/91)(P<0.001),抗菌治疗时间从中位数(IQR)15(12-16)天缩短至 5(5-8)天(P<0.001)。32 名儿童(18.7%)发生术后腹腔脓肿。女性(OR=2.76,95%CI 1.18-6.48;P=0.02)和入院时脓毒症/感染性休克(OR=4.72,95%CI 1.12-19.97;P=0.035)是术后腹腔脓肿的独立危险因素,但与抗菌方案无关。本研究表明,简化儿童复杂性阑尾炎的一线抗菌方案与减少方案偏差、减少抗生素疗程和相似的结果(术后并发症和住院时间)相关。

相似文献

1
Simplification of first-line antibacterial regimen for complicated appendicitis in children is associated with better adherence to guidelines and reduced use of antibiotics.简化儿童复杂性阑尾炎的一线抗菌治疗方案与更好地遵循指南和减少抗生素使用有关。
Int J Antimicrob Agents. 2018 Aug;52(2):293-296. doi: 10.1016/j.ijantimicag.2018.04.010. Epub 2018 Apr 18.
2
Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.环丙沙星联合甲硝唑与哌拉西林-他唑巴坦治疗复杂性腹腔内感染的药物经济学
Surg Infect (Larchmt). 2008 Jun;9(3):325-33. doi: 10.1089/sur.2007.010.
3
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.哌拉西林/他唑巴坦与头孢噻肟加甲硝唑治疗需手术的儿童腹腔内感染
Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):643-6. doi: 10.1007/s100960100581.
4
Contemporary Microbiology and Antimicrobial Treatment of Complicated Appendicitis: The Value of a Short-term Study.当代微生物学与复杂性阑尾炎的抗菌治疗:短期研究的价值。
Pediatr Infect Dis J. 2019 Nov;38(11):e290-e294. doi: 10.1097/INF.0000000000002420.
5
Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis.患者选择对小儿非手术与手术治疗单纯性急性阑尾炎的疗效影响。
JAMA Surg. 2016 May 1;151(5):408-15. doi: 10.1001/jamasurg.2015.4534.
6
Does compliance with antibiotic prophylaxis in pediatric simple appendicitis matter?小儿单纯性阑尾炎中抗生素预防用药的依从性重要吗?
J Surg Res. 2017 Aug;216:1-8. doi: 10.1016/j.jss.2017.04.002. Epub 2017 Apr 21.
7
Predictors of outcome for children with perforated appendicitis initially treated with non-operative management.初始采用非手术治疗的穿孔性阑尾炎患儿的预后预测因素。
Surg Infect (Larchmt). 2004 Winter;5(4):349-56. doi: 10.1089/sur.2004.5.349.
8
Monotherapy versus multi-drug therapy for the treatment of perforated appendicitis in children.儿童穿孔性阑尾炎治疗的单药治疗与多药治疗对比
Surg Infect (Larchmt). 2003 Winter;4(4):327-33. doi: 10.1089/109629603322761382.
9
[Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery].哌拉西林-他唑巴坦与甲硝唑+庆大霉素在急诊结直肠手术中临床及微生物学疗效的对照、开放、平行组研究
Cir Esp. 2006 Jun;79(6):365-9. doi: 10.1016/s0009-739x(06)70892-2.
10
Community-acquired complicated intra-abdominal infections in children hospitalized during 1995-2004 at a paediatric surgery department.1995年至2004年期间在一家儿科外科住院的儿童社区获得性复杂性腹腔内感染。
Scand J Infect Dis. 2009;41(10):720-6. doi: 10.1080/00365540903159261.

引用本文的文献

1
Bacterial peritonitis in paediatric appendicitis; microbial epidemiology and antimicrobial management.小儿阑尾炎中的细菌性腹膜炎;微生物流行病学和抗菌管理。
Ann Clin Microbiol Antimicrob. 2023 Jun 3;22(1):45. doi: 10.1186/s12941-023-00591-1.
2
Perioperative Antibiotic Prophylaxis in Pediatric Cardiac Surgery-Simple Is Better.小儿心脏手术围手术期抗生素预防——简单更好。
Antibiotics (Basel). 2022 Dec 30;12(1):66. doi: 10.3390/antibiotics12010066.